Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
71 participants
OBSERVATIONAL
2022-05-11
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Apical Periodontitis and Atherosclerotic Cardiovascular Diseases
NCT05792787
Effect of Lifestyle on Caries and Apical Periodontitis
NCT06072742
Inflammation-Related Endothelial Barrier Dysfunction in Patients With Apical Periodontitis
NCT07292363
Periodontal Assessment in Depression Patients
NCT04260880
Changes in Bruxism Activity After Periodontal Treatment in Patients With Periodontitis
NCT07053878
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The inclusion criteria of the study are healthy patients older than 18 years, the ability and willingness to give informed consent, and the presence of untreated periapical lesions for the case group. Participants without apical periodontitis will be included in the control group. Participants affected by systemic diseases such as diabetes or rheumatoid arthritis, those using corticosteroid drugs, and those in stage 3 or 4 of periodontitis will be excluded. Additional exclusion criteria include the use of antibiotics within the last 6 months, inability to give informed consent, and pregnancy or lactation.
Seventy-one subjects fulfilling the described criteria will be enrolled and allocated into two distinct groups based on the presence or absence of apical periodontitis. Group 1 will consist of patients with radiographic evidence of AP, and Group 2 will consist of healthy controls free from clinical and radiographic signs of AP. The AP+ group will include patients with at least one tooth showing radiographic evidence of apical radiolucency.
To perform the initial screening, participants will undergo panoramic radiography, clinical examination, and periapical radiographs using the long cone paralleling technique to assess suspected AP. The following parameters will be recorded:
* The number of decayed, missing, and filled teeth (DMFT index)
* The number of teeth with apical periodontitis
* Periapical Index (PAI) Score
All mental health assessments will be conducted using standardized psychiatric scales, including the Hamilton Depression Rating Scale (HAM-D) and the Hamilton Anxiety Rating Scale (HAM-A), to evaluate the severity of depression and anxiety, respectively.
Additionally, smoking status (current, former, or non-smoker) will be recorded to explore its association with apical periodontitis and its potential impact on anxiety and depression scores.
The results expected from this study are:
* A potential correlation between apical periodontitis and increased anxiety and depression scores (HAM-A and HAM-D).
* A possible association between smoking habits and the severity of mental health conditions in relation to apical periodontitis.
This study may help to elucidate the connection between oral and mental health, highlighting the importance of holistic health care approaches that consider both physical and psychological factors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case Group (AP+):
This group consists of participants who have apical periodontitis (AP), an oral inflammatory condition. These participants are diagnosed with AP based on radiographic evidence. They may exhibit symptoms of AP, but AP is often asymptomatic, so radiographic confirmation is key.
Clinical and Radiographic assessment + Questionnaires
* Clinical and radiographic examination to assess oral health and apical periodontitis.
* Questionnaires to assess Anxiety and depression.
Control Group (AP-):
This group consists of participants who do not have apical periodontitis (AP). These participants are healthy individuals with no clinical or radiographic signs of apical periodontitis. They will be matched with the case group based on age, gender, and other relevant characteristics, but they will not have any dental lesions related to apical periodontitis.
Clinical and Radiographic assessment + Questionnaires
* Clinical and radiographic examination to assess oral health and apical periodontitis.
* Questionnaires to assess Anxiety and depression.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical and Radiographic assessment + Questionnaires
* Clinical and radiographic examination to assess oral health and apical periodontitis.
* Questionnaires to assess Anxiety and depression.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age above 18 years old;
* Presence of an untreated periapical lesion for the case group;
* Absence of a periapical lesion for the control group.
Exclusion Criteria
* Rheumatoid Arthritis;
* Use of corticosteroid drugs;
* Stage 3 and 4 of periodontitis;
* Inability or unwillingness to give informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Siena
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simone Grandini
Professore
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simone Grandini, PhD, DDS
Role: PRINCIPAL_INVESTIGATOR
University of Siena
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliera Universitaria Senese
Siena, Tuscany, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MHAP001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.